These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 22722403)

  • 21. Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity.
    Sartor GC; Powell SK; Brothers SP; Wahlestedt C
    J Neurosci; 2015 Nov; 35(45):15062-72. PubMed ID: 26558777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury.
    Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK
    Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors.
    Ramadoss M; Mahadevan V
    Drug Discov Today; 2018 Jan; 23(1):76-89. PubMed ID: 28943305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An apicomplexan bromodomain protein, TgBDP1, associates with diverse epigenetic factors to regulate essential transcriptional processes in
    Fleck K; McNutt S; Chu F; Jeffers V
    mBio; 2023 Aug; 14(4):e0357322. PubMed ID: 37350586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting BET bromodomains for cancer treatment.
    Jung M; Gelato KA; Fernández-Montalván A; Siegel S; Haendler B
    Epigenomics; 2015; 7(3):487-501. PubMed ID: 26077433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Epigenetic 'Readers' with Natural Compounds for Cancer Interception.
    Damiani E; Duran MN; Mohan N; Rajendran P; Dashwood RH
    J Cancer Prev; 2020 Dec; 25(4):189-203. PubMed ID: 33409252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BET bromodomain proteins are required for glioblastoma cell proliferation.
    Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
    Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.
    Michaeloudes C; Mercado N; Clarke C; Bhavsar PK; Adcock IM; Barnes PJ; Chung KF
    J Immunol; 2014 May; 192(10):4913-4920. PubMed ID: 24733848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes.
    Xiao Y; Liang L; Huang M; Qiu Q; Zeng S; Shi M; Zou Y; Ye Y; Yang X; Xu H
    Rheumatology (Oxford); 2016 Jan; 55(1):173-84. PubMed ID: 26324948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone modifications in transcriptional activation during plant development.
    Berr A; Shafiq S; Shen WH
    Biochim Biophys Acta; 2011 Oct; 1809(10):567-76. PubMed ID: 21777708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators.
    Tsujikawa LM; Kharenko OA; Stotz SC; Rakai BD; Sarsons CD; Gilham D; Wasiak S; Fu L; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
    Biomed Pharmacother; 2022 Aug; 152():113230. PubMed ID: 35687908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation.
    Stock CJW; Michaeloudes C; Leoni P; Durham AL; Mumby S; Wells AU; Chung KF; Adcock IM; Renzoni EA; Lindahl GE
    Biomed Res Int; 2019; 2019():1484736. PubMed ID: 31119153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
    Biswas S; Rao CM
    Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-Molecule Targeting of BET Proteins in Cancer.
    French CA
    Adv Cancer Res; 2016; 131():21-58. PubMed ID: 27451123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
    Rajendran P; Johnson G; Li L; Chen YS; Dashwood M; Nguyen N; Ulusan A; Ertem F; Zhang M; Li J; Sun D; Huang Y; Wang S; Leung HC; Lieberman D; Beaver L; Ho E; Bedford M; Chang K; Vilar E; Dashwood R
    Cancer Res; 2019 Mar; 79(5):918-927. PubMed ID: 30643017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.
    Segura MF; Fontanals-Cirera B; Gaziel-Sovran A; Guijarro MV; Hanniford D; Zhang G; González-Gomez P; Morante M; Jubierre L; Zhang W; Darvishian F; Ohlmeyer M; Osman I; Zhou MM; Hernando E
    Cancer Res; 2013 Oct; 73(20):6264-76. PubMed ID: 23950209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis.
    Belkina AC; Blanton WP; Nikolajczyk BS; Denis GV
    J Leukoc Biol; 2014 Mar; 95(3):451-60. PubMed ID: 24319289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells.
    Wasiak S; Tsujikawa LM; Daze E; Gilham D; Stotz SC; Rakai BD; Sarsons CD; Fu L; Azhar S; Jahagirdar R; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
    Atherosclerosis; 2023 Jan; 364():10-19. PubMed ID: 36455344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.
    De Rijck J; de Kogel C; Demeulemeester J; Vets S; El Ashkar S; Malani N; Bushman FD; Landuyt B; Husson SJ; Busschots K; Gijsbers R; Debyser Z
    Cell Rep; 2013 Nov; 5(4):886-94. PubMed ID: 24183673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.